This opportunity is no longer accepting applications.
grant PAR-24-063

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)

The Blueprint Neurotherapeutics Network (BPN) is a program that helps neuroscience researchers develop small molecule drugs for neurological conditions, taking them through the discovery and development phases up to clinical testing. Participants work with NIH-funded experts and organizations on different aspects like medicinal chemistry, pharmacokinetics, and toxicology. Projects can start at…

The Blueprint Neurotherapeutics Network (BPN) supports neuroscience investigators in advancing small molecule drug discovery and development projects into clinical stages. Participants conduct disease-specific research and collaborate with NIH-funded consultants and contract research organizatio…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Neurological Disorders and Stroke
Phase: Phase II

Eligibility

SBIR applicants only: U.S. small businesses that are >50% owned by multiple venture capital operating companies, hedge funds, private equity firms, or any combination thereof (subject to SBA rules; no single VC/HF/PE may own >50% unless itself a qualifying small business)

Only United States Small Business Concerns (SBCs) are eligible applicants.

Definition and ownership/control (SBA/SBIR/STTR):

  • Organized for profit with a place of business in the United States; operates primarily in the U.S. or makes a significant contribution to the U.S. econ…

Dates

Opportunity Released: November 1, 2023
Open for Submission: November 1, 2023
Submission Deadline: August 18, 2026
Application Window Closes: August 18, 2026

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.